INDIA Cases - 236,184, Deaths - 6,649
Global Cases - 6,823,277, Deaths - 397,324
New Delhi: Following the Indian Council for Medical Research (ICMR) on Monday asked state governments to stop using the rapid antibody testing kits that India had procured from China over inaccurate results, China has expressed deep concern over the decision of the Indian government. The antibody testing kits were exported to India by two Chinese firms- Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics. While the kits were being used in India it started giving a wide variation in its results leading to immediate halt in its use by the ICMR.
In a statement, China has asserted that the country always keeps quality as its priority before exporting its medical products to other countries. Chinese Embassy Spokesperson Ji Rong said that it is 'unfair and irresponsible for certain individuals to label Chinese products as 'faulty' and look at the issues with preemptive prejudice'. However, she further stated that China would continue to help India to fight against COVID-19 pandemic and will be working jointly to protect the people of both countries from the infection.
Ji Rong, in her statement, also assured that China is taking stringent actions to help India fighting this pandemic by maintaining close contact with the ICMR and the two Chinese companies. She also alerted that if the medical professionals did not use these testing kits as per the product instructions then it may lead to variation in results, adding that the kits are performing well in many countries of Asia, Europe and Latin America.
Deeply concerned: China on ICMR's decision to not use COVID-19 test kits from two Chinese firms https://t.co/a3tB8PyW2R— TOI India (@TOIIndiaNews) April 28, 2020
While mentioning viruses as common enemy of mankind, Ji Rong further added that both the countries could only overcome this pandemic if they will work together and effectively.
Meanwhile, the ICMR has asked all the states and union territories to return the rapid antibody testing kits to the central government so that it can be sent back to China. Notably, the Indian government has still not made the payment of the rapid testing kits procured by the two Chinese firms yet.